cached image

Suzanne Marie de la Monte, MD, Cornell University, MPH, Johns Hopkins University

Affiliations: 
Neurosurgery Brown University, Providence, RI 
Area:
Alzheimer's, alcoholic neurodegeneration, and fetal alcohol syndrome. Experimentally, we examine how insulin deficiency and/or insulin resistance leads
Website:
http://www.research.brown.edu/research/profile.php?id=1133802224
Google:
"Suzanne de la Monte"
Bio:

Suzanne de la Monte has had a major research interest in studying the roles of insulin and insulin like growth factors in relation to brain function since 1994. Suzanne was probably the first to recognize the importance of insulin as a factor mediating the survival of neurons in the central nervous system, and the consequences of impaired insulin actions on brain development and function. Her research led to the discoveries that the insulin gene is expressed in the brain, and that in Alzheimer’s disease, neurodegeneration is associated with brain insulin deficiency as well as brain insulin resistance. The absence of associated Type 1 or Type 2 diabetes, led to the term, “Type 3 Diabetes”, to reflect the selective brain insulin deficiency and insulin resistance in Alzheimer’s disease. Suzanne’s research has also demonstrated a connection between brain insulin or insulin like growth factor resistance and other forms of neurodegeneration such as alcoholic brain disease. These paradigm shifting concepts could lead to novel approaches to the diagnosis and treatment of Alzheimer’s disease, and possibly other types of dementia. Suzanne actively engages Brown Undergraduate and Medical Students in these dynamic research efforts.

Suzanne received both her B.A. and M.D. from Cornell University. She later received a Masters in Public Health (MPH) from the Johns Hopkins School of Hygiene and Public Health. Suzanne did a residency in Anatomic Pathology at Johns Hopkins and a second residency in Neuropathology at Massachusetts General Hospital. She also did a postdoctoral fellowship in Molecular and Cell Biology at Massachusetts General Hospital. Suzanne was a member of the faculty at Massachusetts General Hospital and Harvard Medical School until 2000; from 2000 to the present, Suzanne has been a member of the Faculty at Rhode Island Hospital and the Brown Medical School.
(Show less)

Mean distance: 14.96 (cluster 24)
 
SNBCP
Cross-listing: Alzheimer's Tree

BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Lee HK, Kwon B, Lemere CA, et al. (2016) mTORC2 (Rictor) in Alzheimer's Disease and Reversal of Amyloid-β Expression-Induced Insulin Resistance and Toxicity in Rat Primary Cortical Neurons. Journal of Alzheimer's Disease : Jad
Carter JJ, Tong M, Silbermann E, et al. (2008) Ethanol impaired neuronal migration is associated with reduced aspartyl-asparaginyl-beta-hydroxylase expression. Acta Neuropathologica. 116: 303-15
de la Monte SM, Jhaveri A, Maron BA, et al. (2007) Nitric oxide synthase 3-mediated neurodegeneration after intracerebral gene delivery. Journal of Neuropathology and Experimental Neurology. 66: 272-83
Lahousse SA, Carter JJ, Xu XJ, et al. (2006) Differential growth factor regulation of aspartyl-(asparaginyl)-beta-hydroxylase family genes in SH-Sy5y human neuroblastoma cells. Bmc Cell Biology. 7: 41
de la Monte SM, Wands JR. (2006) Molecular indices of oxidative stress and mitochondrial dysfunction occur early and often progress with severity of Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 9: 167-81
Lester-Coll N, Rivera EJ, Soscia SJ, et al. (2006) Intracerebral streptozotocin model of type 3 diabetes: relevance to sporadic Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 9: 13-33
de la Monte SM, Tamaki S, Cantarini MC, et al. (2006) Aspartyl-(asparaginyl)-beta-hydroxylase regulates hepatocellular carcinoma invasiveness. Journal of Hepatology. 44: 971-83
Steen E, Terry BM, Rivera EJ, et al. (2005) Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease--is this type 3 diabetes? Journal of Alzheimer's Disease : Jad. 7: 63-80
de la Monte SM, Wands JR. (2004) Alzheimer-associated neuronal thread protein mediated cell death is linked to impaired insulin signaling. Journal of Alzheimer's Disease : Jad. 6: 231-42
Lahousse SA, Stopa EG, Mulberg AE, et al. (2003) Reduced expression of the cystic fibrosis transmembrane conductance regulator gene in the hypothalamus of patients with Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 5: 455-62
See more...